SM Biochemicals LLC

Supplier of Fluoromethyl Ketones (FMK), Difluorophenoxymethylketone (Q-VD-OPH), Caspase/
Apoptosis  Detection Kits, Calpain Inhibitors, Cathepsin Inhibitors, Antiviral Peptide inhibitor
(Picornavirus 2A Proteinases),  Peptide Aldehyde (CHO), Caspase / Apoptosis Inhibitors and
Substrates, Diazomethylketone Inhibitors, AMC/ AFC/PNA/ Cresyl voilet/ Thiobenzyl Substrates (SBzl),
wide variety of  peptides for both research and bulk pharmeceutical trials. Active Pharmaceutical
Ingredients, Custom Synthesis of Peptide and Organic molecules.

Q-VD-OPH, Z-VD-OPH, Boc-D-OPH, Z-DEVD-OPH, Z-VAD(OMe)-FMK, Z-VAD-FMK( non methylated)
Boc-D-FMK,Z-DEVD-FMK, Z-IETD-FMK, Z-LEHD-FMK, Z-VEID-FMK, Z-AEVD-FMK, Z-VDVAD-FMK,
Z-LEVD-FMK,Z-ATAD-FMK, Biotin-VAD-FMK, Biotin-DEVD-FMK, Z-FA-FMK, Biotin-FA-FMK, Z-FF-FMK,
Z-LLY-FMK, Z-VAM-FMK, FITC-VAD-FMK, FAM-VAD-FMK, FAM-DEVD-FMK, SR-VAD-FMK, SR-DEVD-FMK,
CASPASE / APOPTOSIS INHIBITORS AND DETECTION KITS  CATHEPSIN, CALPAIN INHIBITORS, PEPTIDE
ALDEHYDE INHIBITORS,  FLUOROGENIC (AMC, AFC), GLY-PHE-DIAZOMETHYLKETONE,  CHROMOGENIC
( PNA ) SUBSTRATES.

CRESYL VOILET SUBSTRATES ( A new cell  permeable fluorogenic substrate) THIOBENZYL ESTER
(SBzl) SUBSTRATES.

SM Biochemicals offers a wide variety of peptides including Adrenocorticotropic Hormone(ACTH),
Adrenomedullins, ADAM Substrate, Agatoxin IVa, Akt Substrate, All D Beta Amyloid, Alpha MSH, Amylin,
Amyloid, Angiotensin, APP, a great number of Beta Amyloids which have been found to offer useful
tools in Alzheimer's research. Bradykinin, Calcitonin,Casein Kinase, Cecropin B,Cecropin P1,porcine,
Corticotropin, Endothelins, Endothelin Antagonists, Exendin 3,Enzyme Inhibitors, Fibrinogen Binding,
Fibrinopeptide, Flag Peptide, Furin InhibitorII,Galanin, Galantide, Gamma Secretase Inhibitor, Gastric
Inhibitory Peptide, human / GIP, human, Gastrin, Gastrin Releasing Peptide, human / GRP, Ghrelin,
Glucagon,Growth Hormone Releasing Factor, H.I.V. -1 Protease, Hepatitis C Virus, HIVSubstrate IV, HIV
Substrate IV Inhibitor I, Humanin, KISS, Leumorphin, LH-RH Free Acid, Locustapyrokinin, MG-132/
Proteosome inhibitor, MMP Substrates and Inhibitors, MOG Protein, Motlin Peptides, Myosin, MZ
Peptides, Neuropeptide, Neurotensin, NFF2 MMP subsrates, Non A Beta component Amyloid, Obestatin,
Oxerin A and Oxerin B ( Human), Orntide, Oxyntomodulin, PACAP, Pancreastatin, Pancreatic
polypeptide, Parathyroid Hormone,PKA Inhibitor and Substrate, Plasminogen activator substrate,
Protein Kinase, PTH Peptide/Protein, PYY Peptide/Protein, Sarafotoxin peptides, Somatostatin peptides,
Syntide, TNF converting enzyme substrate, Tyrosine specific protein kinase, Vasoactive intestinal
constrictor, VIP peptides, VIP Antagonist, VIP Receptor, Xenopsin.

We provide peptides for both research and bulk pharmeceutical trials. A staff with decades of
experience in peptide chemistry will help you with the design and synthesis of your custom peptides
and with the technical information necessary to help you optimize your research results.

Active Pharmaceutical Ingredients ( APIs and Intermediates). Pharmaceutically active peptides.

Call our number (714)993-9461 or (925)876-3111 or email at info@smbiochemicals.com
1
5
3
4
2
Prev
Catalog #
Peptide Name
Sequence
Size
Price ( $ )
SM645-50
Amylin, rat
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg
-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-A
sn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-
Gly-Ser-Asn-Thr-Tyr-NH2
0.5 MG
195
SM645-50
Amylin, rat
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg
-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-A
sn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-
Gly-Ser-Asn-Thr-Tyr-NH2
1 MG
325
SM641-81
Amyloid Blocker
Acetyl-Gln-Lys-Leu-Val-Phe-Phe-NH2
5 MG
140
SM641-64
Amyloid Fragment
(Pro18,Asp21)
(17-21)
Leu-Pro-Phe-Phe-Asp-OH
5 MG
160
SM641-87
Amyloid Precursor
7-Methoxycoumarin-4acetyl-Ser-Glu-Val-Asn-
Leu-Asp-Ala-Glu-Phe-Arg-e-DNP-Lys-Arg-Arg-
NH2
1 MG
195
SM641-87
Amyloid Precursor
7-Methoxycoumarin-4acetyl-Ser-Glu-Val-Asn-
Leu-Asp-Ala-Glu-Phe-Arg-e-DNP-Lys-Arg-Arg-
NH2
5 MG
650
SM131-41
Angiotensin
Fragment ( 1-7 )  
acetate
Asp-Arg-Val-Tyr-Ile-His-Pro-OH
5 MG
95
SM137-40
Angiotensin I
[Asn1,Val5,Asn9],
salmon
Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH
5 MG
160
SM137-36
Angiotensin I
[Val5,Asn9], bullfrog
Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH
5 MG
160
SM131-63
Angiotensin II
[Sar1,Ile8]
Sarcosine-Arg-Val-Tyr-Ile-His-Pro-Ile-OH
5 MG
160
SM131-49
Angiotensin II,
human
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
5 MG
105
SM131-65
Angiotensin II-[Sar1]
Sarcosine-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
5 MG
140
SM131-76
Angiotensin III,
human) /
Angiotensin II-[Des
Asp1]
Arg-Val-Tyr-Ile-His-Pro-Phe-OH
10 MG
140
SM131-82
Angiotensinogen
(1-14) Renin
Substrate (porcine)
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-
Val-Tyr-Ser-OH
10 MG
315
SM640-27
APP (354-371)
Lys-Ala-Val-Ile-Gln-His-Phe-Gln-Glu-Lys-Val-
Glu-Ser-Leu-Glu-Gln-Glu-Ala-OH
1 MG
235
SM640-27
APP (354-371)
Lys-Ala-Val-Ile-Gln-His-Phe-Gln-Glu-Lys-Val-
Glu-Ser-Leu-Glu-Gln-Glu-Ala-OH
5 MG
695
SM649-10
APP Beta
Secretase Inhibitor
Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-200-Val-
Ala-Glu-Phe-OH
1 MG
215
SM649-23
APP Gamma
Secretase Inhibitor
3-5difluorophenacetyl-Ala-S-Pheglycine-Methy
lester
5 MG
110
SM649-22
APP Gamma
Secretase Inhibitor
3-5difluorophenacetyl-Ala-S-Pheglycine-
t-butylester
5 MG
110
SM450-29
Arg-Gly-Asp-Ser
(RGDS)
Arg-Gly-Asp-Ser-OH
25 MG
145
SM641-14
[Gly22] Beta
Amyloid (1-40),
human ( Arctic )
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
y-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-OH
1 MG
325
SM641-14
[Gly22] Beta
Amyloid (1-40),
human ( Arctic )
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
y-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-OH
5 MG
1125
SM641-22
[Gly22] Beta
Amyloid (1-42),
human (Arctic)
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
y-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
0.5 MG
295
SM641-22
[Gly22] Beta
Amyloid (1-42),
human (Arctic)
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
y-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
1 MG
395
SM641-45
Beta Amyloid  
[Glu11] (10-16),
human
Tyr-Glu-Val-His-His-Gln-Lys-OH
1 MG
100
SM641-45
Beta Amyloid  
[Glu11] (10-16),
human
Tyr-Glu-Val-His-His-Gln-Lys-OH
5 MG
275
SM641-13
Beta Amyloid  
[Nle35] (1-40),
human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-050-Val-Gly-Gly-Val-Val-OH
0.5 MG
230
SM641-13
Beta Amyloid  
[Nle35] (1-40),
human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-050-Val-Gly-Gly-Val-Val-OH
1 MG
320
SM641-13
Beta Amyloid  
[Nle35] (1-40),
human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-050-Val-Gly-Gly-Val-Val-OH
5 MG
1095
SM641-21
Beta Amyloid
(10-20), human
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe
-OH
0.5 MG
95
SM641-21
Beta Amyloid
(10-20), human
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe
-OH
1 MG
125
SM641-35
Beta Amyloid (1-16)
[Gln11], human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln
-Val-His-His-Gln-Lys-OH
1 MG
130
SM641-35
Beta Amyloid (1-16)
[Gln11], human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln
-Val-His-His-Gln-Lys-OH
5 MG
395
SM642-36
Beta Amyloid
(1-16), rat
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Gl
u-Val-Arg-His-Gln-Lys-OH
1 MG
140
SM642-36
Beta Amyloid
(1-16), rat
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Gl
u-Val-Arg-His-Gln-Lys-OH
5 MG
410
SM641-19
Beta Amyloid
(12-28), human
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-OH
0.5 MG
95
SM641-19
Beta Amyloid
(12-28), human
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-OH
1 MG
140
SM641-17
Beta Amyloid
(1-28), [Gln11],
human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-OH
0.5 MG
140
SM641-17
Beta Amyloid
(1-28), [Gln11],
human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-OH
1 MG
215
SM641-17
Beta Amyloid
(1-28), [Gln11],
human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-OH
5 MG
725
SM641-88
Beta Amyloid
(13-16), human
His-His-Gln-Lys-OH
1 MG
95
SM641-88
Beta Amyloid
(13-16), human
His-His-Gln-Lys-OH
5 MG
230
SM642-10
Beta Amyloid
(1-40), rat
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Gl
u-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gl
y-Leu-Met-Val-Gly-Gly-Val-Val-OH
0.5 MG
245
SM642-10
Beta Amyloid
(1-40), rat
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Gl
u-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gl
y-Leu-Met-Val-Gly-Gly-Val-Val-OH
1 MG
395
SM642-10
Beta Amyloid
(1-40), rat
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Gl
u-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gl
y-Leu-Met-Val-Gly-Gly-Val-Val-OH
5 MG
1095
SM641-01
Beta Amyloid
[Glu11] (1-40),
human - HFIP
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-OH
0.5 MG
245
SM641-01
Beta Amyloid
[Glu11] (1-40),
human - HFIP
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-OH
1 MG
395
SM641-15
Beta Amyloid
(1-42), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
0.5 MG
295
SM641-15
Beta Amyloid
(1-42), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
1 MG
395
SM641-15
Beta Amyloid
(1-42), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
5 MG
1450
SM641-00
Beta Amyloid
(1-42), human -
HFIP
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
0.5 MG
295
SM641-00
Beta Amyloid
(1-42), human -
HFIP
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
1 MG
475
SM642-15
Beta Amyloid
(1-42), rat
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Gl
u-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gl
y-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
0.5 MG
295
SM642-15
Beta Amyloid
(1-42), rat
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Gl
u-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gl
y-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
1 MG
395
SM641-20
Beta Amyloid
(1-43), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-OH
0.5 MG
310
SM641-20
Beta Amyloid
(1-43), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu
-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gl
u-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-OH
1 MG
450
6
Next
7
8
9
10
11
12
13
14